Adage Capital Management reported a 8.38% stake in SAB Biotherapeutics SABS · 6,405,553 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 8.38%
Last report: First report
Shares held: 6,405,553 sh
Class: Common Stock, par value $0.0001 per share
Stock: SAB Biotherapeutics SABS
Holder: Adage Capital Management
Event date: 26/06/30
Filed: 26/08/12

First 5%+ report · 8.38% stake

SAB Biotherapeutics trades, last 26 weeks

What else happened in SAB Biotherapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Adage Capital Management's other 5% stake reports

Adage Capital Management
5% stakeForefront Tech Holdings Acquisition
5% stake
Forefront Tech Holdings Acquisition
FTHA
9% stake
900,000 sh
9% stake
Filed 08/12
Adage Capital Management
5% stakeEquillium
5% stake
Equillium
EQ
7.25% stake
4,832,767 sh
7.25% stake
Filed 08/12
Adage Capital Management
5% stakeEnergy Transition Special Opportunities
5% stake
Energy Transition Special Opportunities
ETSS
9% stake
1,350,000 sh
9% stake
Filed 08/12
Adage Capital Management
5% stakeCybin
5% stake
Cybin
HELP
5.29% stake
3,289,250 sh
5.29% stake
Filed 08/12
Adage Capital Management
5% stakeYorkville International Capital
5% stake
Yorkville International Capital
YICC
7.83% stake
1,800,000 sh
7.83% stake
Filed 08/12